Cite

HARVARD Citation

    Watanabe, A. et al. (2022). Safety and immunogenicity of a quadrivalent seasonal influenza vaccine adjuvanted with hydroxypropyl-β-cyclodextrin: A phase 1 clinical trial. Vaccine. 40 (31), pp. 4150-4159. [Online]. 
  
Back to record